$YEXT

Yext, Inc.

CIK:0001614178|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025	Jul. 31, 2026	Jul. 31, 2025
Income Statement [Abstract]
Revenue	$ 111,103	$ 113,094	$ 219,019	$ 222,577
Cost of revenue	27,267	28,060	56,462	55,165
Gross profit	83,836	85,034	162,557	167,412
Operating expenses:
Sales and marketing	26,309	32,069	55,706	68,278
Research and development	19,373	23,352	40,854	45,248
General and administrative	20,592	(61)	42,854	23,094
Total operating expenses	66,274	55,360	139,414	136,620
Income from operations	17,562	29,674	23,143	30,792
Interest income	437	1,179	1,180	1,811
Interest expense	(3,565)	(2,277)	(6,667)	(2,919)
Other expense, net	(230)	(45)	(395)	(400)
Income from operations before income taxes	14,204	28,531	17,261	29,284
Provision for income taxes	(1,055)	(1,780)	(1,487)	(1,763)
Net income	$ 13,149	$ 26,751	$ 15,774	$ 27,521
Net income per share attributable to common stockholders, basic (in dollars per share)	$ 0.13	$ 0.22	$ 0.15	$ 0.22
Net income per share attributable to common stockholders, diluted (in dollars per share)	$ 0.13	$ 0.03	$ 0.15	$ 0.05
Weighted-average number of shares used in computing net income per share attributable to common stockholders, basic (in shares)	100,094,307	122,854,629	105,813,505	124,229,932
Weighted-average number of shares used in computing net income per share attributable to common stockholders, diluted (in shares)	103,110,326	130,800,808	107,165,224	131,013,284
Other comprehensive (loss) income:
Foreign currency translation adjustment	$ (374)	$ 21	$ (825)	$ 3,304
Unrealized (loss) gain on marketable securities, net	0	(9)	9	(9)
Total comprehensive income	$ 12,775	$ 26,763	$ 14,958	$ 30,816

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 31, 2026	Jul. 31, 2025
Operating activities:
Net income	$ 15,774	$ 27,521
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	12,420	13,643
Impairment of long-lived assets	4,689	0
Bad debt expense	1,163	953
Stock-based compensation expense	19,995	25,621
Amortization of operating lease right-of-use assets	4,546	4,683
Adjustments to contingent consideration	10	(21,600)
Other, net	426	664
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:
Accounts receivable	50,202	47,282
Prepaid expenses and other current assets	(5,139)	(2,017)
Costs to obtain revenue contracts	4,531	7,004
Other long term assets	(807)	6,847
Accounts payable, accrued expenses and other current liabilities	(17,712)	65
Unearned revenue	(37,260)	(46,452)
Operating lease liabilities	(7,380)	(7,022)
Other long term liabilities	(81)	(11,060)
Net cash provided by operating activities	45,377	46,132
Investing activities:
Capital expenditures	(688)	(1,135)
Cash paid in acquisitions, net of cash acquired	(1,068)	(18,801)
Net cash used in investing activities	(1,756)	(19,936)
Financing activities:
Proceeds from exercise of stock options	0	439
Proceeds from debt issuance	49,500	99,000
Repurchase of common stock	(150,906)	(45,380)
Payments for taxes related to net share settlement of stock-based compensation awards	(7,805)	(14,002)
Payments of deferred financing costs	(298)	(877)
Deferred acquisition payments	(2,905)	0
Proceeds, net from employee stock purchase plan withholdings	1,118	1,568
Net cash (used in) provided by financing activities	(111,296)	40,748
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,130)	3,940
Net (decrease) increase in cash, cash equivalents and restricted cash	(68,805)	70,884
Cash, cash equivalents and restricted cash at beginning of period	169,174	138,654
Cash, cash equivalents and restricted cash at end of period	$ 100,369	$ 209,538

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2026	Jan. 31, 2026
Current assets:
Cash and cash equivalents	$ 86,828	$ 154,123
Restricted cash, current	0	1,500
Accounts receivable, net of allowances of $2,159 and $2,345, respectively	68,797	120,637
Prepaid expenses and other current assets	26,071	21,253
Costs to obtain revenue contracts, current	16,917	20,291
Total current assets	198,613	317,804
Property and equipment, net	25,992	30,088
Operating lease right-of-use assets	43,987	50,908
Restricted cash, non-current	13,541	13,551
Costs to obtain revenue contracts, non-current	9,343	10,663
Goodwill	111,235	110,801
Intangible assets, net	77,647	85,133
Other long term assets	3,589	2,828
Total assets	483,947	621,776
Current liabilities:
Accounts payable, accrued expenses and other current liabilities	34,614	52,528
Unearned revenue, current	179,594	217,465
Operating lease liabilities, current	18,950	18,590
Contingent consideration, current	6,800	8,200
Total current liabilities	239,958	296,783
Operating lease liabilities, non-current	55,020	61,915
Long term debt, net	147,704	97,959
Other long term liabilities	5,603	5,698
Total liabilities	448,285	462,355
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, $0.001 par value per share; 50,000,000 shares authorized at July 31, 2026 and January 31, 2026; zero shares issued and outstanding at July 31, 2026 and January 31, 2026	0	0
Common stock, $0.001 par value per share; 500,000,000 shares authorized at July 31, 2026 and January 31, 2026; 136,537,014 and 158,368,658 shares issued at July 31, 2026 and January 31, 2026, respectively; 99,283,687 and 122,933,027 shares outstanding at July 31, 2026 and January 31, 2026, respectively	137	158
Additional paid-in capital	898,016	1,027,900
Accumulated other comprehensive loss	(2,385)	(1,569)
Accumulated deficit	(653,475)	(669,249)
Treasury stock, at cost	(206,631)	(197,819)
Total stockholders’ equity	35,662	159,421
Total liabilities and stockholders’ equity	$ 483,947	$ 621,776